microRNAs and Other Serological Markers of Liver Fibrosis in Patients with Alcohol-Related Liver Cirrhosis

<b>Background</b>: It is essential to identify novel non-invasive markers of liver fibrosis for clinical and scientific purposes. Thus, the goal of our survey was to assess the serological expression of selected microRNAs (miRNAs) in patients with alcohol-related liver cirrhosis (ALC) and to correlate them with other existing markers. <b>Methods</b>: Two hundred and thirty-nine persons were enrolled in the study: one hundred and thirty-nine with ALC and one hundred healthy controls. Serological expression of miR-126-3p, miR-197-3p and miR-1-3p was evaluated in all participants. Direct markers of liver fibrosis (PICP, PIIINP, PDGF-AB, TGF-α and laminin) together with indirect indices (AAR, APRI, FIB-4 and GPR) were also assessed. The additional evaluation concerned hematological parameters: MPV, PDW, PCT, RDW, MPR, RPR NLR, PLR and RLR. <b>Results</b>: The expression of miR-197-3p was lower in ALC compared to controls (<i>p</i> < 0.0001). miR-126-3p correlated negatively with AST (<i>p</i> < 0.05) and positively with miR-197-3p (<i>p</i> < 0.001). miR-197-3p correlated with direct markers of liver fibrosis-positively with PDGF-AB (<i>p</i> < 0.005) and negatively with TGF-α (<i>p</i> < 0.01). Significant negative relationships were noticed between miR-1-3p and the number of neutrophils (<i>p</i> < 0.05), TGF-α (<i>p</i> < 0.05) and laminin (<i>p</i> < 0.05). <b>Conclusions</b>: The achieved results and observed correlations prove the potential involvement of the examined miRNAs in the process of liver fibrosis, giving a novel insight into the diagnostics of liver cirrhosis.

Authors

Institutions

Publication Details

Journal
Biomedicines
Published
2024-09-16
DOI
https://doi.org/10.3390/biomedicines12092108
Citations
2
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.77

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

microRNAs and Other Serological Markers of Liver Fibrosis in Patients with Alcohol-Related Liver Cirrhosis

Ewa Tywanek, Halina Cichoż‐Lach, Witold Jeleniewicz, Karolina Szczygieł et al.
2 citations
Biomedicines
Liver Disease Diagnosis and Treatment
0.77
article

microRNAs and Other Serological Markers of Liver Fibrosis in Patients with Alcohol-Related Liver Cirrhosis

Ewa Tywanek, Halina Cichoż‐Lach, Witold Jeleniewicz, Karolina Szczygieł, Joanna Kozicka, Agata Michalak, Marek Cybulski, Małgorzata Guz
article en
2 citations

Abstract

<b>Background</b>: It is essential to identify novel non-invasive markers of liver fibrosis for clinical and scientific purposes. Thus, the goal of our survey was to assess the serological expression of selected microRNAs (miRNAs) in patients with alcohol-related liver cirrhosis (ALC) and to correlate them with other existing markers. <b>Methods</b>: Two hundred and thirty-nine persons were enrolled in the study: one hundred and thirty-nine with ALC and one hundred healthy controls. Serological expression of miR-126-3p, miR-197-3p and miR-1-3p was evaluated in all participants. Direct markers of liver fibrosis (PICP, PIIINP, PDGF-AB, TGF-α and laminin) together with indirect indices (AAR, APRI, FIB-4 and GPR) were also assessed. The additional evaluation concerned hematological parameters: MPV, PDW, PCT, RDW, MPR, RPR NLR, PLR and RLR. <b>Results</b>: The expression of miR-197-3p was lower in ALC compared to controls (<i>p</i> < 0.0001). miR-126-3p correlated negatively with AST (<i>p</i> < 0.05) and positively with miR-197-3p (<i>p</i> < 0.001). miR-197-3p correlated with direct markers of liver fibrosis-positively with PDGF-AB (<i>p</i> < 0.005) and negatively with TGF-α (<i>p</i> < 0.01). Significant negative relationships were noticed between miR-1-3p and the number of neutrophils (<i>p</i> < 0.05), TGF-α (<i>p</i> < 0.05) and laminin (<i>p</i> < 0.05). <b>Conclusions</b>: The achieved results and observed correlations prove the potential involvement of the examined miRNAs in the process of liver fibrosis, giving a novel insight into the diagnostics of liver cirrhosis.

BiomedicinesVol. 12(9)
Medical University of Lublin (PL), Lublin Oncology Center (PL)
Agencja Badań Medycznych
Good health and well-being
Openalex Percentile: Top 25%
Liver Disease Diagnosis and Treatment
0.77
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.